These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26875576)

  • 21. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis.
    Akova Budak B; Baykara M; Kıvanç SA; Yilmaz H; Cicek S
    Cutan Ocul Toxicol; 2016; 35(2):126-30. PubMed ID: 26100380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials].
    Lin ZQ; Huang YL; Huang P; Chen Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):900-6. PubMed ID: 21211409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of linezolid in liver transplant patients.
    Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
    Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
    Rao N; Ziran BH; Wagener MM; Santa ER; Yu VL
    Clin Infect Dis; 2004 Apr; 38(8):1058-64. PubMed ID: 15095207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
    Sterzik H; Soriano A; Mohamad AM; Martínez JA; Fernandez J; Cobos N; Morata L; Mensa J
    Scand J Infect Dis; 2011 Oct; 43(10):765-70. PubMed ID: 21696252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
    Hong J; Moon SM; Ahn HK; Sym SJ; Park YS; Park J; Cho YK; Cho EK; Shin DB; Lee JH
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):994-9. PubMed ID: 23571460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin.
    Equils O; da Costa C; Wible M; Lipsky BA
    BMC Infect Dis; 2016 Sep; 16(1):476. PubMed ID: 27600290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation.
    Okada A; Kariya M; Irie K; Okada Y; Hiramoto N; Hashimoto H; Kajioka R; Maruyama C; Kasai H; Hamori M; Nishimura A; Shibata N; Fukushima K; Sugioka N
    J Clin Pharmacol; 2018 Sep; 58(9):1140-1149. PubMed ID: 29762865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2005; 23(9):945-64. PubMed ID: 16153136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
    Rubinstein E; Cammarata S; Oliphant T; Wunderink R;
    Clin Infect Dis; 2001 Feb; 32(3):402-12. PubMed ID: 11170948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid vs. vancomycin in treatment of methicillin-resistant staphylococcus aureus infections: a meta-analysis.
    Li J; Zhao QH; Huang KC; Li ZQ; Zhang LY; Qin DY; Pan F; Huang WX
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3974-3979. PubMed ID: 28975963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens.
    Huang DB; File TM; Torres A; Shorr AF; Wilcox MH; Hadvary P; Dryden M; Corey GR
    Clin Ther; 2017 Aug; 39(8):1706-1718. PubMed ID: 28756068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
    Krueger WA; Unertl KE
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.